不同药物对多囊卵巢综合征患者糖尿病风险干预的研究进展

Research progress of different drugs on diabetes risk intervention in patient with polycystic ovary syndrome

多囊卵巢综合征(PCOS)是一种与糖尿病、脑卒中、冠心病等相关的多系统疾病,PCOS患者发生糖尿病的风险明显升高,肥胖、胰岛素抵抗等是其主要危险因素。目前,针对PCOS患者糖尿病风险的干预措施主要为药物治疗与生活方式干预。此外,早期糖尿病筛查及定期随访也有助于提高患者的生活质量。本文主要就不同药物在PCOS患者糖尿病风险干预的研究作一综述,以期为后期药物研究和临床诊疗提供依据。

Polycystic ovary syndrome(PCOS)is currently considered to be a multisystem disease associated with diabetes,stroke,coronary heart disease and so on.There is a significant increasing risk of developing diabetes in patients with PCOS,and obesity and insulin resistance are the main risk factors.Currently,the main interventions for diabetes risk in PCOS patients are drug therapy and lifestyle intervention.Early diabetes screening and regular follow-up are helpful to improve the quality of life.This paper reviews the researches on diabetes risk intervention with different drugs in PCOS patients,so as to provide the basis for future research and clinical diagnosis and treatment.